Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM

NCT00274612 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

801

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Telmisartan
DRUG: Ramipril

Sponsor

Boehringer Ingelheim